Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12

AUTHORS

Katrina Bauer, Carol Parise, Vincent Caggiano

ABSTRACT

BACKGROUND: The 2007 St Gallen international expert consensus statement describes three risk categories and provides recommendations for treatment of early breast cancer. The set of recommendations on how to best treat primary breast cancer is recognized and used by clinicians worldwide. We now examine the variability of five-year survival of the 2007 St Gallen Risk Classifications utilizing the ER/PR/HER2 subtypes. METHODS: Using the population-based California Cancer Registry, 114,786 incident cases of Stages 1-3 invasive breast cancer diagnosed between 2000 and 2006 were identified. Cases were assigned to Low, Intermediate, or High Risk categories. Five-year-relative survival was computed for the three St Gallen risk categories and for the ER/PR/HER2 subtypes for further differentiation. RESULTS AND DISCUSSION: There were 9,124 (13%) cases classified as Low Risk, 44,234 (65%) cases as Intermediate Risk, and 14,340 (21%) as High Risk. Within the Intermediate Risk group, 33,735 (76%) were node-negative (Intermediate Risk 2) and 10,499 (24%) were node-positive (Intermediate Risk 3). For the High Risk group, 6,149 (43%) had 1 to 3 positive axillary lymph nodes (High Risk 4) and 8,191 (57%) had four or more positive lymph nodes (High Risk 5). Using five-year relative survival as the principal criterion, we found the following: a) There was very little difference between the Low Risk and Intermediate Risk categories; b) Use of the ER/PR/HER2 subtypes within the Intermediate and High Risk categories separated each into a group with better five-year survival (ER-positive) and a group with worse survival (ER-negative), irrespective of HER2-status; c) The heterogeneity of the High Risk category was most evident when one examined the ER/PR/HER2 subtypes with four or more positive axillary lymph nodes; (d) HER2-positivity did not always translate to worse survival, as noted when one compared the triple positive subtype (ER+/PR+/HER2+) to the triple negative subtype (ER-/PR-/HER2-); and (e) ER-negativity appeared to be a stronger predictor of poor survival than HER2-positivity. CONCLUSION: The use of ER/PR/HER2 subtype highlights the marked heterogeneity of the Intermediate and High Risk categories of the 2007 St Gallen statements. The use of ER/PR/HER2 subtypes and correlation with molecular classification of breast cancer is recommended. More... »

PAGES

228

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-10-228

DOI

http://dx.doi.org/10.1186/1471-2407-10-228

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030682398

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20492696


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "California", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization, Fluorescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphatic Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, ErbB-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Estrogen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Progesterone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "California Department of Public Health", 
          "id": "https://www.grid.ac/institutes/grid.236815.b", 
          "name": [
            "California Cancer Registry, California Department of Public Health, Public Health Institute, Sacramento, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bauer", 
        "givenName": "Katrina", 
        "id": "sg:person.0650243264.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650243264.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sutter Institute for Medical Research", 
          "id": "https://www.grid.ac/institutes/grid.430769.f", 
          "name": [
            "Sutter Institute for Medical Research, 2801 Capitol Ave Suite 400, Sacramento, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parise", 
        "givenName": "Carol", 
        "id": "sg:person.0716356464.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716356464.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sutter Institute for Medical Research", 
          "id": "https://www.grid.ac/institutes/grid.430769.f", 
          "name": [
            "Sutter Institute for Medical Research, 2801 Capitol Ave Suite 400, Sacramento, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Caggiano", 
        "givenName": "Vincent", 
        "id": "sg:person.0764471664.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764471664.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1524-4741.2009.00822.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001316307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1524-4741.2009.00822.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001316307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.5207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002938892"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.12.2747", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005163434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005674252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007114596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-009-0334-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009011697", 
          "https://doi.org/10.1245/s10434-009-0334-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp317", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009280839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(09)70012-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010608425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdn590", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011470778"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014256568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.20665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016939906"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.99.143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017058798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdn439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018775523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2168.2002.02113.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020741195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022156409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022949162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.breast.2007.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025868356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.07.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028170076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.299.13.1574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029228821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4757-3656-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032089040", 
          "https://doi.org/10.1007/978-1-4757-3656-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4757-3656-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032089040", 
          "https://doi.org/10.1007/978-1-4757-3656-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4757-3656-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032089040", 
          "https://doi.org/10.1007/978-1-4757-3656-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa021967", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038600096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.8411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040833745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hye056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042089659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042592360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdp322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042592360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.295.21.2492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043089674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr1639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044880794", 
          "https://doi.org/10.1186/bcr1639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr1639", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044880794", 
          "https://doi.org/10.1186/bcr1639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1309/2yxrleqvppnrwhga", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051309777"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/80.7.471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059815027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.03.088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/2531329", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069976776"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12", 
    "datePublishedReg": "2010-12-01", 
    "description": "BACKGROUND: The 2007 St Gallen international expert consensus statement describes three risk categories and provides recommendations for treatment of early breast cancer. The set of recommendations on how to best treat primary breast cancer is recognized and used by clinicians worldwide. We now examine the variability of five-year survival of the 2007 St Gallen Risk Classifications utilizing the ER/PR/HER2 subtypes.\nMETHODS: Using the population-based California Cancer Registry, 114,786 incident cases of Stages 1-3 invasive breast cancer diagnosed between 2000 and 2006 were identified. Cases were assigned to Low, Intermediate, or High Risk categories. Five-year-relative survival was computed for the three St Gallen risk categories and for the ER/PR/HER2 subtypes for further differentiation.\nRESULTS AND DISCUSSION: There were 9,124 (13%) cases classified as Low Risk, 44,234 (65%) cases as Intermediate Risk, and 14,340 (21%) as High Risk. Within the Intermediate Risk group, 33,735 (76%) were node-negative (Intermediate Risk 2) and 10,499 (24%) were node-positive (Intermediate Risk 3). For the High Risk group, 6,149 (43%) had 1 to 3 positive axillary lymph nodes (High Risk 4) and 8,191 (57%) had four or more positive lymph nodes (High Risk 5). Using five-year relative survival as the principal criterion, we found the following: a) There was very little difference between the Low Risk and Intermediate Risk categories; b) Use of the ER/PR/HER2 subtypes within the Intermediate and High Risk categories separated each into a group with better five-year survival (ER-positive) and a group with worse survival (ER-negative), irrespective of HER2-status; c) The heterogeneity of the High Risk category was most evident when one examined the ER/PR/HER2 subtypes with four or more positive axillary lymph nodes; (d) HER2-positivity did not always translate to worse survival, as noted when one compared the triple positive subtype (ER+/PR+/HER2+) to the triple negative subtype (ER-/PR-/HER2-); and (e) ER-negativity appeared to be a stronger predictor of poor survival than HER2-positivity.\nCONCLUSION: The use of ER/PR/HER2 subtype highlights the marked heterogeneity of the Intermediate and High Risk categories of the 2007 St Gallen statements. The use of ER/PR/HER2 subtypes and correlation with molecular classification of breast cancer is recommended.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2407-10-228", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2433000", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2432951", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2432964", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2699859", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer", 
    "pagination": "228", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "922aa6619280cf2801a34b8943b28f15e5e0938cf5e9df97f0dc637a75a4be43"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20492696"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-10-228"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030682398"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-10-228", 
      "https://app.dimensions.ai/details/publication/pub.1030682398"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2407-10-228"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-228'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-228'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-228'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-228'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      82 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-10-228 schema:about N0a6075f06e59424f9a56bd7cd6c6801c
2 N181af0d385e8474680f2ffce3f939844
3 N213bd51a092b4cc5bc6d22edcf9aedd7
4 N4cb623065aad4a1fb06753a650ca7acf
5 N4d27f13b8a5d4e62a9e54215b410700b
6 N5868decb0ded4744aee3c025d5a10c05
7 N6ad25949177340a493de7a493625f72b
8 N6ea596322a044f73af64c7639267de76
9 N7343225de6a44163a2b710e01955518b
10 N7a0f6903e79948dea2a01a14443606ba
11 N83a151a70c4c488d9df46f26ca75c746
12 N8b6e03b0b8924f519596543bdf93d0ec
13 N913ddc0702f54a09a0273d8f7e5e1734
14 N99b90f790f604b5d80c14828c92465e9
15 Na25c702e26a248bb8c33fa4c1c50c4f3
16 Nacfeecd9d9694f9fb97cdd3c984c4940
17 Nbcd3e624653a42068cb7157a15e5757e
18 Nc8863d55269f49d78f12b2437c11667f
19 Nccaa6604c3ce45c88e31ec4212cba50d
20 Ncefcffbfb0a04feb8db8bac02eb4e997
21 Nd761a361a6414d49ad7bd9c85278285c
22 Nd7bd19fe1fa14f848cb139f12d1edad2
23 Nf8179776724a457298c741422bd34d00
24 anzsrc-for:11
25 anzsrc-for:1112
26 schema:author N496799fcfd1e4080adaadede2977848e
27 schema:citation sg:pub.10.1007/978-1-4757-3656-4
28 sg:pub.10.1186/bcr1639
29 sg:pub.10.1245/s10434-009-0334-7
30 https://doi.org/10.1001/jama.295.21.2492
31 https://doi.org/10.1001/jama.299.13.1574
32 https://doi.org/10.1002/bjs.5207
33 https://doi.org/10.1002/cncr.20665
34 https://doi.org/10.1002/cncr.21030
35 https://doi.org/10.1002/cncr.22618
36 https://doi.org/10.1002/cncr.23243
37 https://doi.org/10.1016/j.breast.2007.06.007
38 https://doi.org/10.1016/s0959-8049(09)70012-7
39 https://doi.org/10.1046/j.1365-2168.2002.02113.x
40 https://doi.org/10.1056/nejmoa021967
41 https://doi.org/10.1056/nejmoa041588
42 https://doi.org/10.1093/annonc/mdm271
43 https://doi.org/10.1093/annonc/mdn439
44 https://doi.org/10.1093/annonc/mdn590
45 https://doi.org/10.1093/annonc/mdp317
46 https://doi.org/10.1093/annonc/mdp322
47 https://doi.org/10.1093/jjco/hye056
48 https://doi.org/10.1093/jnci/80.7.471
49 https://doi.org/10.1111/j.1524-4741.2009.00822.x
50 https://doi.org/10.1200/jco.2003.03.088
51 https://doi.org/10.1200/jco.2004.07.018
52 https://doi.org/10.1200/jco.2004.99.143
53 https://doi.org/10.1200/jco.2007.12.2747
54 https://doi.org/10.1200/jco.2007.14.8411
55 https://doi.org/10.1309/2yxrleqvppnrwhga
56 https://doi.org/10.2307/2531329
57 schema:datePublished 2010-12
58 schema:datePublishedReg 2010-12-01
59 schema:description BACKGROUND: The 2007 St Gallen international expert consensus statement describes three risk categories and provides recommendations for treatment of early breast cancer. The set of recommendations on how to best treat primary breast cancer is recognized and used by clinicians worldwide. We now examine the variability of five-year survival of the 2007 St Gallen Risk Classifications utilizing the ER/PR/HER2 subtypes. METHODS: Using the population-based California Cancer Registry, 114,786 incident cases of Stages 1-3 invasive breast cancer diagnosed between 2000 and 2006 were identified. Cases were assigned to Low, Intermediate, or High Risk categories. Five-year-relative survival was computed for the three St Gallen risk categories and for the ER/PR/HER2 subtypes for further differentiation. RESULTS AND DISCUSSION: There were 9,124 (13%) cases classified as Low Risk, 44,234 (65%) cases as Intermediate Risk, and 14,340 (21%) as High Risk. Within the Intermediate Risk group, 33,735 (76%) were node-negative (Intermediate Risk 2) and 10,499 (24%) were node-positive (Intermediate Risk 3). For the High Risk group, 6,149 (43%) had 1 to 3 positive axillary lymph nodes (High Risk 4) and 8,191 (57%) had four or more positive lymph nodes (High Risk 5). Using five-year relative survival as the principal criterion, we found the following: a) There was very little difference between the Low Risk and Intermediate Risk categories; b) Use of the ER/PR/HER2 subtypes within the Intermediate and High Risk categories separated each into a group with better five-year survival (ER-positive) and a group with worse survival (ER-negative), irrespective of HER2-status; c) The heterogeneity of the High Risk category was most evident when one examined the ER/PR/HER2 subtypes with four or more positive axillary lymph nodes; (d) HER2-positivity did not always translate to worse survival, as noted when one compared the triple positive subtype (ER+/PR+/HER2+) to the triple negative subtype (ER-/PR-/HER2-); and (e) ER-negativity appeared to be a stronger predictor of poor survival than HER2-positivity. CONCLUSION: The use of ER/PR/HER2 subtype highlights the marked heterogeneity of the Intermediate and High Risk categories of the 2007 St Gallen statements. The use of ER/PR/HER2 subtypes and correlation with molecular classification of breast cancer is recommended.
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree true
63 schema:isPartOf N7e68d820ff4b4c0e9c60a859087ebbad
64 Nc5b992e6081245f0b051e2d528237ae9
65 sg:journal.1024632
66 schema:name Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
67 schema:pagination 228
68 schema:productId N3d33cda75cec43a89d8d1ff6596a7d14
69 N553451a739bf4c94afac92eb138c28d7
70 N6867d11302d34496ac8ce0e917989206
71 Nb33bdbbde8ef4deba2495b05a88b5abd
72 Ne558e8b701ed4e9e804f189023e46809
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030682398
74 https://doi.org/10.1186/1471-2407-10-228
75 schema:sdDatePublished 2019-04-10T21:37
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher Na1fb0d4c1c0c4151b36ae779a0f6797e
78 schema:url http://link.springer.com/10.1186%2F1471-2407-10-228
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N0a6075f06e59424f9a56bd7cd6c6801c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Adult
84 rdf:type schema:DefinedTerm
85 N181af0d385e8474680f2ffce3f939844 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name California
87 rdf:type schema:DefinedTerm
88 N213bd51a092b4cc5bc6d22edcf9aedd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Receptor, ErbB-2
90 rdf:type schema:DefinedTerm
91 N2dabbd8a8d5343b48613bcd790b153f8 rdf:first sg:person.0716356464.42
92 rdf:rest N8ec6f03e33b248a78393bbda78898684
93 N3d33cda75cec43a89d8d1ff6596a7d14 schema:name doi
94 schema:value 10.1186/1471-2407-10-228
95 rdf:type schema:PropertyValue
96 N496799fcfd1e4080adaadede2977848e rdf:first sg:person.0650243264.24
97 rdf:rest N2dabbd8a8d5343b48613bcd790b153f8
98 N4cb623065aad4a1fb06753a650ca7acf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Practice Guidelines as Topic
100 rdf:type schema:DefinedTerm
101 N4d27f13b8a5d4e62a9e54215b410700b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Survival Analysis
103 rdf:type schema:DefinedTerm
104 N553451a739bf4c94afac92eb138c28d7 schema:name pubmed_id
105 schema:value 20492696
106 rdf:type schema:PropertyValue
107 N5868decb0ded4744aee3c025d5a10c05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Time Factors
109 rdf:type schema:DefinedTerm
110 N6867d11302d34496ac8ce0e917989206 schema:name nlm_unique_id
111 schema:value 100967800
112 rdf:type schema:PropertyValue
113 N6ad25949177340a493de7a493625f72b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Breast Neoplasms
115 rdf:type schema:DefinedTerm
116 N6ea596322a044f73af64c7639267de76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Neoplasm Staging
118 rdf:type schema:DefinedTerm
119 N7343225de6a44163a2b710e01955518b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name In Situ Hybridization, Fluorescence
121 rdf:type schema:DefinedTerm
122 N7a0f6903e79948dea2a01a14443606ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Risk Factors
124 rdf:type schema:DefinedTerm
125 N7e68d820ff4b4c0e9c60a859087ebbad schema:volumeNumber 10
126 rdf:type schema:PublicationVolume
127 N83a151a70c4c488d9df46f26ca75c746 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 N8b6e03b0b8924f519596543bdf93d0ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Biomarkers, Tumor
132 rdf:type schema:DefinedTerm
133 N8ec6f03e33b248a78393bbda78898684 rdf:first sg:person.0764471664.51
134 rdf:rest rdf:nil
135 N913ddc0702f54a09a0273d8f7e5e1734 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Treatment Outcome
137 rdf:type schema:DefinedTerm
138 N99b90f790f604b5d80c14828c92465e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Immunohistochemistry
140 rdf:type schema:DefinedTerm
141 Na1fb0d4c1c0c4151b36ae779a0f6797e schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 Na25c702e26a248bb8c33fa4c1c50c4f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Risk Assessment
145 rdf:type schema:DefinedTerm
146 Nacfeecd9d9694f9fb97cdd3c984c4940 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Lymphatic Metastasis
148 rdf:type schema:DefinedTerm
149 Nb33bdbbde8ef4deba2495b05a88b5abd schema:name dimensions_id
150 schema:value pub.1030682398
151 rdf:type schema:PropertyValue
152 Nbcd3e624653a42068cb7157a15e5757e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Middle Aged
154 rdf:type schema:DefinedTerm
155 Nc5b992e6081245f0b051e2d528237ae9 schema:issueNumber 1
156 rdf:type schema:PublicationIssue
157 Nc8863d55269f49d78f12b2437c11667f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Receptors, Progesterone
159 rdf:type schema:DefinedTerm
160 Nccaa6604c3ce45c88e31ec4212cba50d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Female
162 rdf:type schema:DefinedTerm
163 Ncefcffbfb0a04feb8db8bac02eb4e997 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Registries
165 rdf:type schema:DefinedTerm
166 Nd761a361a6414d49ad7bd9c85278285c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Predictive Value of Tests
168 rdf:type schema:DefinedTerm
169 Nd7bd19fe1fa14f848cb139f12d1edad2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Aged
171 rdf:type schema:DefinedTerm
172 Ne558e8b701ed4e9e804f189023e46809 schema:name readcube_id
173 schema:value 922aa6619280cf2801a34b8943b28f15e5e0938cf5e9df97f0dc637a75a4be43
174 rdf:type schema:PropertyValue
175 Nf8179776724a457298c741422bd34d00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Receptors, Estrogen
177 rdf:type schema:DefinedTerm
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
182 schema:name Oncology and Carcinogenesis
183 rdf:type schema:DefinedTerm
184 sg:grant.2432951 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2407-10-228
185 rdf:type schema:MonetaryGrant
186 sg:grant.2432964 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2407-10-228
187 rdf:type schema:MonetaryGrant
188 sg:grant.2433000 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2407-10-228
189 rdf:type schema:MonetaryGrant
190 sg:grant.2699859 http://pending.schema.org/fundedItem sg:pub.10.1186/1471-2407-10-228
191 rdf:type schema:MonetaryGrant
192 sg:journal.1024632 schema:issn 1471-2407
193 schema:name BMC Cancer
194 rdf:type schema:Periodical
195 sg:person.0650243264.24 schema:affiliation https://www.grid.ac/institutes/grid.236815.b
196 schema:familyName Bauer
197 schema:givenName Katrina
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650243264.24
199 rdf:type schema:Person
200 sg:person.0716356464.42 schema:affiliation https://www.grid.ac/institutes/grid.430769.f
201 schema:familyName Parise
202 schema:givenName Carol
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716356464.42
204 rdf:type schema:Person
205 sg:person.0764471664.51 schema:affiliation https://www.grid.ac/institutes/grid.430769.f
206 schema:familyName Caggiano
207 schema:givenName Vincent
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764471664.51
209 rdf:type schema:Person
210 sg:pub.10.1007/978-1-4757-3656-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032089040
211 https://doi.org/10.1007/978-1-4757-3656-4
212 rdf:type schema:CreativeWork
213 sg:pub.10.1186/bcr1639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044880794
214 https://doi.org/10.1186/bcr1639
215 rdf:type schema:CreativeWork
216 sg:pub.10.1245/s10434-009-0334-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009011697
217 https://doi.org/10.1245/s10434-009-0334-7
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1001/jama.295.21.2492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043089674
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1001/jama.299.13.1574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029228821
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1002/bjs.5207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002938892
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1002/cncr.20665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016939906
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1002/cncr.21030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007114596
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1002/cncr.22618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005674252
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1002/cncr.23243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014256568
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.breast.2007.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025868356
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/s0959-8049(09)70012-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010608425
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1046/j.1365-2168.2002.02113.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020741195
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1056/nejmoa021967 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038600096
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1056/nejmoa041588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022156409
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1093/annonc/mdm271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022949162
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1093/annonc/mdn439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018775523
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1093/annonc/mdn590 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011470778
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1093/annonc/mdp317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009280839
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1093/annonc/mdp322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042592360
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1093/jjco/hye056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042089659
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1093/jnci/80.7.471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059815027
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1111/j.1524-4741.2009.00822.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001316307
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1200/jco.2003.03.088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203459
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1200/jco.2004.07.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028170076
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1200/jco.2004.99.143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017058798
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1200/jco.2007.12.2747 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005163434
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2007.14.8411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040833745
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1309/2yxrleqvppnrwhga schema:sameAs https://app.dimensions.ai/details/publication/pub.1051309777
270 rdf:type schema:CreativeWork
271 https://doi.org/10.2307/2531329 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069976776
272 rdf:type schema:CreativeWork
273 https://www.grid.ac/institutes/grid.236815.b schema:alternateName California Department of Public Health
274 schema:name California Cancer Registry, California Department of Public Health, Public Health Institute, Sacramento, CA, USA
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.430769.f schema:alternateName Sutter Institute for Medical Research
277 schema:name Sutter Institute for Medical Research, 2801 Capitol Ave Suite 400, Sacramento, CA, USA
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...